103 related articles for article (PubMed ID: 38747910)
1. Aspartate Transaminase-to-Albumin Ratio (ATAR), a Novel Prognostic Index, Predicts Outcomes in Patients with Small-Cell Lung Cancer.
Liu S; Ren H; Zu R; Wang D; Leng P; Luo H
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747910
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer.
Zhang X; Ren H; Tian J; Yang C; Luo H
Heliyon; 2024 Jan; 10(1):e23830. PubMed ID: 38192754
[TBL] [Abstract][Full Text] [Related]
3. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients.
Hong S; Zhou T; Fang W; Xue C; Hu Z; Qin T; Tang Y; Chen Y; Ma Y; Yang Y; Hou X; Huang Y; Zhao H; Zhao Y; Zhang L
Tumour Biol; 2015 May; 36(5):3389-97. PubMed ID: 25527156
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Albumin/Globulin Ratio Predicts the Prognosis for Small-Cell Lung Cancer.
Zhou T; He X; Fang W; Zhan J; Hong S; Qin T; Ma Y; Sheng J; Zhou N; Zhao Y; Huang Y; Zhang L
Medicine (Baltimore); 2016 Mar; 95(12):e3097. PubMed ID: 27015181
[TBL] [Abstract][Full Text] [Related]
5. Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer.
Zhou T; Zhan J; Hong S; Hu Z; Fang W; Qin T; Ma Y; Yang Y; He X; Zhao Y; Huang Y; Zhao H; Zhang L
Sci Rep; 2015 Jun; 5():10481. PubMed ID: 26084991
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis.
Wu F; Yang S; Tang X; Liu W; Chen H; Gao H
Thorac Cancer; 2020 Apr; 11(4):888-897. PubMed ID: 32087605
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of body mass index and serum albumin as the indicators of nutritional status in small cell lung cancer.
Tas F; Ozturk A; Erturk K
Postgrad Med; 2024 Mar; 136(2):208-217. PubMed ID: 38456321
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between Pretreatment Serum Apolipoprotein Level and Prognosis of Small Cell Lung Cancer Patients].
Dong Y; Wang H; Shan D; Zhang L; Yu Z
Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):845-851. PubMed ID: 33070513
[TBL] [Abstract][Full Text] [Related]
9. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Kinetics of Low-Density Lipoprotein Cholesterol and Its Prognostic Value in Limited Stage Small Cell Lung Cancer Patients.
Liu T; Zhou T; Luo F; Yang Y; Zhao S; Huang Y; Zhao H; Zhang L; Zhao Y
Cancer Control; 2021; 28():10732748211028257. PubMed ID: 34184581
[TBL] [Abstract][Full Text] [Related]
11. A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer.
Zhou T; Hong S; Hu Z; Hou X; Huang Y; Zhao H; Liang W; Zhao Y; Fang W; Wu X; Qin T; Zhang L
Tumour Biol; 2015 Jan; 36(1):337-43. PubMed ID: 25256672
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
Wang X; Jiang R; Li K
Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
Ma X; Zhang Z; Chen X; Zhang J; Nie J; Da L; Hu W; Tian G; Wu D; Han J; Han S; Long J; Wang Y; Fang J
Thorac Cancer; 2021 Jun; 12(12):1841-1850. PubMed ID: 33955685
[TBL] [Abstract][Full Text] [Related]
14. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
15. The Significance of Controlling Nutritional Status (CONUT) Score as a Novel Prognostic Parameter in Small Cell Lung Cancer.
Yılmaz A; Tekin SB; Bilici M; Yılmaz H
Lung; 2020 Aug; 198(4):695-704. PubMed ID: 32424800
[TBL] [Abstract][Full Text] [Related]
16. High Systemic Immune-Inflammation Index (SII) Represents an Unfavorable Prognostic Factor for Small Cell Lung Cancer Treated with Etoposide and Platinum-Based Chemotherapy.
Wang C; Jin S; Xu S; Cao S
Lung; 2020 Apr; 198(2):405-414. PubMed ID: 32016563
[TBL] [Abstract][Full Text] [Related]
17. Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute.
Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M; Kanda S; Koizumi T
Chemotherapy; 2019; 64(3):129-137. PubMed ID: 31622969
[TBL] [Abstract][Full Text] [Related]
18. Serum low-density lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC).
Zhou T; Zhan J; Fang W; Zhao Y; Yang Y; Hou X; Zhang Z; He X; Zhang Y; Huang Y; Zhang L
BMC Cancer; 2017 Apr; 17(1):269. PubMed ID: 28410578
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of C-reactive protein/albumin ratio on the overall survival of patients with advanced nonsmall cell lung cancers receiving palliative chemotherapy.
Koh YW; Lee HW
Medicine (Baltimore); 2017 May; 96(19):e6848. PubMed ID: 28489774
[TBL] [Abstract][Full Text] [Related]
20. The prognostic values of prognostic nutritional index in extensive-stage small-cell lung cancer.
Bahçeci A; Kötek Sedef A; Işik D
Anticancer Drugs; 2022 Jan; 33(1):e534-e540. PubMed ID: 34407045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
